Bolt Total Assets from 2010 to 2024

BOLT Stock

USD 0.60 0.02 3.45%

Bolt Biotherapeutics Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 147.8 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

159.8 M

Current Value

147.8 M

Quarterly Volatility

93.6 M

Credit Downgrade

Yuan Drop

Covid

Check Bolt Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bolt Biotherapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 6.5 M, Interest Income of 6.5 M or Depreciation And Amortization of 2.5 M, as well as many indicators such as Price To Sales Ratio of 5.11, Dividend Yield of 0.0 or PTB Ratio of 0.39. Bolt financial statements analysis is a perfect complement when working with Bolt Biotherapeutics Valuation or Volatility modules.

Check out the analysis of Bolt Biotherapeutics Correlation against competitors.

For more information on how to buy Bolt Stock please use our How to Invest in Bolt Biotherapeutics guide.

Latest Bolt Biotherapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Bolt Biotherapeutics over the last few years. Total assets refers to the total amount of Bolt Biotherapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bolt Biotherapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Bolt Biotherapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bolt Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 159.78 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Bolt Total Assets Regression Statistics

	Arithmetic Mean	72,125,981
	Geometric Mean	36,324,845
	Coefficient Of Variation	129.82
	Mean Deviation	73,949,572
	Median	15,975,000
	Standard Deviation	93,634,862
	Sample Variance	8767.5T
	Range	291.7M
	R-Value	0.71
	Mean Square Error	4668.1T
	R-Squared	0.51
	Significance	0
	Slope	14,887,582
	Total Sum of Squares	122744.8T

Bolt Total Assets History

	2024	147.8 M
	2023	159.8 M
	2022	227.8 M
	2021	307.7 M
	2020	46.5 M
	2019	48.4 M

Other Fundumenentals of Bolt Biotherapeutics

Intangibles To Total Assets

Bolt Biotherapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Term Debt	Property Plant Equipment	Current Deferred Revenue	Net Receivables	Deferred Long Term Liab	Common Stock
Total Assets		0.93	0.9	0.68	-0.81	0.95	0.2	0.93	0.99	0.99	0.87	0.91	0.95	0.45	-0.33	0.59
Total Stockholder Equity	0.93		0.93	0.55	-0.7	0.83	-0.16	1.0	0.94	0.95	0.69	0.76	0.82	0.46	-0.26	0.54
Net Tangible Assets	0.9	0.93		0.67	-0.86	0.85	-0.12	0.93	0.9	0.9	0.76	0.81	0.87	0.71	-0.58	0.73
Net Debt	0.68	0.55	0.67		-0.89	0.73	0.34	0.55	0.7	0.68	0.75	0.8	0.81	0.66	-0.57	0.83
Retained Earnings	-0.81	-0.7	-0.86	-0.89		-0.89	-0.25	-0.7	-0.82	-0.8	-0.9	-0.91	-0.88	-0.84	0.72	-0.92
Accounts Payable	0.95	0.83	0.85	0.73	-0.89		0.34	0.83	0.96	0.95	0.96	0.97	0.92	0.56	-0.42	0.71
Total Liab	0.2	-0.16	-0.12	0.34	-0.25	0.34		-0.16	0.17	0.13	0.5	0.42	0.34	-0.12	-0.05	0.06
Net Invested Capital	0.93	1.0	0.93	0.55	-0.7	0.83	-0.16		0.94	0.95	0.69	0.76	0.82	0.46	-0.26	0.54
Total Current Assets	0.99	0.94	0.9	0.7	-0.82	0.96	0.17	0.94		1.0	0.87	0.91	0.92	0.48	-0.32	0.64
Net Working Capital	0.99	0.95	0.9	0.68	-0.8	0.95	0.13	0.95	1.0		0.84	0.89	0.91	0.46	-0.3	0.62
Short Term Debt	0.87	0.69	0.76	0.75	-0.9	0.96	0.5	0.69	0.87	0.84		0.99	0.91	0.58	-0.48	0.71
Property Plant Equipment	0.91	0.76	0.81	0.8	-0.91	0.97	0.42	0.76	0.91	0.89	0.99		0.95	0.57	-0.43	0.71
Current Deferred Revenue	0.95	0.82	0.87	0.81	-0.88	0.92	0.34	0.82	0.92	0.91	0.91	0.95		0.51	-0.47	0.64
Net Receivables	0.45	0.46	0.71	0.66	-0.84	0.56	-0.12	0.46	0.48	0.46	0.58	0.57	0.51		-0.87	0.94
Deferred Long Term Liab	-0.33	-0.26	-0.58	-0.57	0.72	-0.42	-0.05	-0.26	-0.32	-0.3	-0.48	-0.43	-0.47	-0.87		-0.74
Common Stock	0.59	0.54	0.73	0.83	-0.92	0.71	0.06	0.54	0.64	0.62	0.71	0.71	0.64	0.94	-0.74

Click cells to compare fundamentals

About Bolt Biotherapeutics Financial Statements

Bolt Biotherapeutics shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Bolt Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Bolt Biotherapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bolt Biotherapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	159.8 M	147.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Bolt Stock Analysis

When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC